$AXON Axovant Gene Therapies Ltd. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Axovant Gene Therapies Ltd..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Axovant Gene Therapies Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in Axovant Gene Therapies Ltd. for free.

CIK Number: 0001636050
IRS Number: 981333697
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AXON
Company Address: 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON SW1Y 4LB
Former name: Axovant Sciences, Inc., date of change: 2015-03-24
Former name: Roivant Neurosciences Ltd., date of change: 2015-03-09
Former name: Axovant Sciences Ltd., date of change: 2015-03-24

Market Capitalization: $1.28B
Prev close: $12.97
Average Daily Volume: 286,313
Days Low: $12.83
Year Low: $9.19
Year High: $17.66

Axovant Gene Therapies Ltd. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Cheruvu PavanPrincipal Executive Officer7,50097,275shares bought: 7,500 / shares sold: 0 BUYSep 24 20192 months ago
Corcoran GavinEVP of R&D00Sep 24 20192 months ago
Nassif David W.Principal Financial Officer00Sep 24 20192 months ago

View all Axovant Gene Therapies Ltd. insiders.

Axovant Gene Therapies Ltd. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 24 2019AXONAxovant Gene Thera ...Corcoran GavinEVP of R&DOption ExerciseA0.0032,003032,003
Sep 24 2019AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA0.0030,120030,120
Sep 24 2019AXONAxovant Gene Thera ...Cheruvu PavanPrincipal Executive ...Option ExerciseA0.0045,181045,181
Jul 02 2019AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA6.4275,000481,50075,000
Jul 02 2019AXONAxovant Gene Thera ...Nassif David W.Principal Financial ...Option ExerciseA6.42150,000963,000150,000
Jul 01 2019AXONAxovant Gene Thera ...Sundaram Senthil VelDirectorOption ExerciseA6.1918,750116,06318,750
Jun 17 2019AXONAxovant Gene Thera ...Cheruvu PavanChief Executive Off ...BuyP5.217,50039,0757,5000 to 7.5 K
Jun 17 2019AXONAxovant Gene Thera ...Pande AtulDirectorBuyP5.223,37017,5953,3700 to 3.4 K
Apr 17 2019AXONAxovant Sciences L ...Pande AtulDirectorOption ExerciseA1.06255,000270,300255,000
Apr 17 2019AXONAxovant Sciences L ...Bickerstaff GeorgeDirectorOption ExerciseA1.06255,000270,300255,000
Apr 17 2019AXONAxovant Sciences L ...POTTER MYRTLE SDirectorOption ExerciseA1.06255,000270,300255,000
Apr 17 2019AXONAxovant Sciences L ...Torti FrankDirectorOption ExerciseA1.06255,000270,300255,000
Apr 17 2019AXONAxovant Sciences L ...Corcoran GavinEVP of R&DOption ExerciseA1.06200,000212,000200,000
Apr 17 2019AXONAxovant Sciences L ...Corcoran GavinEVP of R&DOption ExerciseA1.06767,000813,020767,000
Apr 17 2019AXONAxovant Sciences L ...Modig BerndtDirectorOption ExerciseA1.06255,000270,300255,000

View all Axovant Gene Therapies Ltd. insider transactions.